← Back to Search

Nonsteroidal Anti-inflammatory Drug

OMT/NSAID for Lower Back Pain

Phase 4
Recruiting
Led By Alexis Cates, DO
Research Sponsored by Albert Einstein Healthcare Network
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
All patients 18 years of age or older with the chief complaint of acute low back pain defined as symptom duration no longer than four weeks prior to ED presentation and having clinical findings of somatic dysfunction (muscle edema, erythema, bogginess, hypertonic muscles, asymmetry of tissue, pain with movement, severe/sharp tenderness).
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 45 minutes
Awards & highlights

Study Summary

This trial will investigate whether osteopathic manipulative treatment (OMT) is more effective than NSAIDs for treating acute low back pain in the emergency department.

Eligible Conditions
  • Lower Back Pain

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~45 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 45 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain score
Secondary outcome measures
Patient Satisfaction
Physician Satisfaction

Trial Design

3Treatment groups
Active Control
Group I: OMT/NSAIDActive Control2 Interventions
Ibuprofen, 800 mg, one time dose
Group II: NSAIDActive Control1 Intervention
Ibuprofen, 800 mg, one time dose
Group III: OMT aloneActive Control1 Intervention
low velocity osteopathic manipulative medicine

Find a Location

Who is running the clinical trial?

Albert Einstein Healthcare NetworkLead Sponsor
63 Previous Clinical Trials
868,448 Total Patients Enrolled
Alexis Cates, DOPrincipal InvestigatorEinstein Healthcare Network
Joseph Herres, DOStudy DirectorEinstein Healthcare Network
1 Previous Clinical Trials
43 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the cap for individuals participating in this experiment?

"Affirmative. Records on clinicaltrials.gov suggest that the trial, posted February 19th 2020, is currently recruiting participants from one medical centre with a total of 174 patients needed for completion."

Answered by AI

Are there any previous experiments that have exclusively utilized osteopathic manipulative treatment?

"Presently, there are 43 ongoing medical trials focused on OMT with 10 of them in the final testing phase. Most clinical studies for this therapy take place in Pittsburgh, PA yet 91 locations across the globe offer it."

Answered by AI

To what conditions is osteopathic manipulative treatment usually applied?

"Osteopathic Manipulative Treatment (OMT) is capable of managing catarrh, relieving muscle spasms, and reducing fever symptoms."

Answered by AI

Is enrollment in this investigation still active?

"Clinicaltrials.gov reveals that this trial is actively recruiting, having been first published on February 19th 2020 and edited recently on November 2nd 2022."

Answered by AI

What kind of risks, if any, are associated with utilizing Osteopathic Manipulative Treatment (OMT) as a standalone therapy?

"By the assessment of our team at Power, OMT stands at a safety rating of 3 due to its Phase 4 status and official approval."

Answered by AI
~34 spots leftby Apr 2025